Cliff Asness’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,334
| Closed | -$502K | – | 2341 |
|
|
2021
Q1 | $502K | Sell |
13,334
-47,558
| -78% | -$1.19M | ﹤0.01% | 1836 |
|
|
2020
Q4 | $1.04M | Sell |
60,892
-160,485
| -72% | -$2.01M | ﹤0.01% | 1495 |
|
|
2020
Q3 | $1.04M | Sell |
221,377
-129,553
| -37% | -$658K | ﹤0.01% | 1394 |
|
|
2020
Q2 | $2.14M | Sell |
350,930
-56,312
| -14% | -$232K | ﹤0.01% | 1129 |
|
|
2020
Q1 | $924K | Sell |
407,242
-42,161
| -9% | -$179K | ﹤0.01% | 1369 |
|
|
2019
Q4 | $2.06M | Buy |
449,403
+311,832
| +227% | +$1.24M | ﹤0.01% | 1261 |
|
|
2019
Q3 | $533K | Buy |
+137,571
| New | +$755K | ﹤0.01% | 1741 |
|
|
2018
Q1 | – | Sell |
-20,255
| Closed | -$444K | – | 2297 |
|
|
2017
Q4 | $444K | Buy |
20,255
+10,287
| +103% | +$331K | ﹤0.01% | 1955 |
|
|
2017
Q3 | $408K | Buy |
9,968
+3,166
| +47% | +$99.4K | ﹤0.01% | 2003 |
|
|
2017
Q2 | $205K | Sell |
6,802
-53,150
| -89% | -$1.66M | ﹤0.01% | 2123 |
|
|
2017
Q1 | $2.17M | Sell |
59,952
-68,143
| -53% | -$3M | ﹤0.01% | 1346 |
|
|
2016
Q4 | $6.42M | Sell |
128,095
-54,813
| -30% | -$2.88M | 0.01% | 927 |
|
|
2016
Q3 | $9.6M | Buy |
182,908
+62,786
| +52% | +$3M | 0.01% | 780 |
|
|
2016
Q2 | $4.97M | Buy |
120,122
+68,943
| +135% | +$3M | 0.01% | 918 |
|
|
2016
Q1 | $2.08M | Sell |
51,179
-35,304
| -41% | -$1.21M | ﹤0.01% | 1227 |
|
|
2015
Q4 | $3.59M | Sell |
86,483
-43,965
| -34% | -$1.47M | 0.01% | 1017 |
|
|
2015
Q3 | $2.01M | Sell |
130,448
-36,930
| -22% | -$794K | ﹤0.01% | 1130 |
|
|
2015
Q2 | $4.16M | Buy |
167,378
+76,178
| +84% | +$1.7M | 0.01% | 899 |
|
|
2015
Q1 | $2.08M | Buy |
+91,200
| New | +$2.3M | ﹤0.01% | 1089 |
|
Cliff Asness's FPRX Position: Q2 2021 in Review
Cliff Asness sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 13,334 shares — an estimated $502K sold.
Cliff Asness first reported a position in FPRX in Q1 2015 and held it in 19 quarters. The position peaked at $9.6M in Q3 2016. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Cliff Asness reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Cliff Asness sold 13,334 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $502K.
- Cliff Asness first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 19 quarters.
- Cliff Asness's Five Prime Therapeutics, Inc. position peaked at $9.6M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on AQR Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.